Envestnet Asset Management Inc Avadel Pharmaceuticals PLC Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$12.55 - $17.22 $192,378 - $263,965	15,329 New	15,329 $258,000
Q2 2023 Aug 04, 2023	SELL	$8.48 - $16.48 $168,260 - $326,996	-19,842 Reduced 58.26%	14,214 $234,000
Q1 2023 May 11, 2023	BUY	$6.41 - $9.95 $218,298 - $338,857	34,056 New	34,056 $311,000
Q3 2022 Nov 10, 2022	SELL	$2.57 - $7.31 $66 - $190	-26 Reduced 0.19%	13,619 $68,000
Q2 2022 Aug 03, 2022	BUY	$1.07 - $6.95 $216 - $1,403	202 Added 1.5%	13,645 $33,000
Q1 2022 May 04, 2022	SELL	$5.46 - $8.29 $33,114 - $50,278	-6,065 Reduced 31.09%	13,443 $92,000
Q4 2021 Feb 04, 2022	BUY	$7.34 - $11.18 $45,280 - $68,969	6,169 Added 46.25%	19,508 $158,000
Q3 2021 Oct 07, 2021	BUY	$6.49 - $9.91 $149 - $227	23 Added 0.17%	13,339 $131,000
Q2 2021 Aug 04, 2021	BUY	$6.73 - $9.05 $89,616 - $120,509	13,316 New	13,316 $90,000
Q4 2020 Feb 02, 2021	SELL	$5.03 - $7.95 $58,061 - $91,766	-11,543 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$5.02 - $8.98 $3,453 - $6,178	688 Added 6.34%	11,543 $58,000
Q2 2020 Jul 08, 2020	BUY	$7.25 - $11.75 $78,698 - $127,546	10,855 New	10,855 $88,000
Q4 2019 Feb 11, 2020	SELL	$3.34 - $7.7 $49,936 - $115,122	-14,951 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$1.92 - $4.47 $397 - $925	-207 Reduced 1.37%	14,951 $62,000
Q2 2019 Aug 02, 2019	BUY	$1.09 - $3.19 $4,642 - $13,586	4,259 Added 39.08%	15,158 $44,000
Q1 2019 May 10, 2019	BUY	$1.44 - $3.29 $377 - $861	262 Added 2.46%	10,899 $16,000
Q4 2018 Feb 13, 2019	BUY	$1.74 - $4.66 $18,508 - $49,568	10,637 New	10,637 $27,000
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $4,471 - $7,825	-1,096 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$6.76 - $11.7 $2,886 - $4,995	-427 Reduced 28.04%	1,096 $8,000
Q4 2017 Feb 20, 2018	BUY	$8.03 - $11.25 $8,110 - $11,362	1,010 Added 196.88%	1,523 $12,000
Q3 2017 Nov 13, 2017	SELL	$8.35 - $10.5 $217 - $273	-26 Reduced 4.82%	513 $5,000
Q2 2017 Aug 14, 2017	BUY	N/A	539	539 $6,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account